GE HealthCare (Nasdaq:GEHC) has unveiled its latest Pristina Via mammography system, crafted to revolutionize the screening experience. The system made its debut at the 2024 Annual Meeting of the Radiological Society of North America in Chicago.
Pristina Via arms mammography technologists with an array of advanced tools, as per a press release. These innovations enhance diagnostic precision while streamlining workflows, supporting more personalized breast care for patients.
With a worldwide shortage of technologists, GE HealthCare points out that the number of women seeking mammograms remains consistent. Additionally, there is a record-breaking demand for more effective and intelligent workflows.
Pristina Via incorporates cutting-edge features to reduce repetitive actions and optimize workflows. It helps mammography technologists maintain their dedication to providing premium, personalized care throughout the screening process.
The system ensures zero-click acquisition for swift, seamless workflows and eliminates wait time between exposures. This allows technologists to operate at their own pace, benefiting from fast image-to-image cycle times. Pristina Via also supports vendor-neutral prior image comparison to streamline the analysis of previous exams. GE HealthCare claims it utilizes the least radiation dose across all breast thicknesses among leading mammography systems.
The Pristina Via platform is future-focused and scalable, offering full backward compatibility. This allows imaging centers to access the latest advancements while providing the adaptability needed to accommodate their ever-evolving requirements.
“Pristina Via marks a significant advancement in our patient-centered Senographe Pristina platform, originally designed by women for women. With its optimized in-room workflow, Pristina Via reduces cumbersome tasks and grants technologists the opportunity to prioritize compassionate, patient-centric care,” noted Jyoti Gupta, president & CEO for Women’s Health and X-ray at GE HealthCare.